Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

NCT01795872 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
278
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer